Cyxone (publ), a biotech company in autoimmune diseases, announces that CFO Henrik Hang leaves the company at his own request. Ola Skanung, previously the CFO at Cyxone, succeeds Henrik.
Henrik joined the company as CFO in August 2021 and has during his time in Cyxone contributed to, among other things, fundraising and restructuring to enable the planned development activities to be performed according to current regulations.
Ola Skanung will take over the role as CFO from Henrik as of November 2022.
“Henrik Hang has been a great asset to the company since he joined Cyxone. Henrik has performed several valuable changes in the company’s internal workflow and structures. We are very grateful for his contributions and wish Henrik the best of luck in his future engagements. We are at the same time pleased to welcome Ola Skanung to Cyxone. Ola knows the company well from previous years and brings a lot of knowledge and experience in his role,” comments Carl-Magnus Högerkorp, acting CEO, Cyxone.